Cell fate decisions during early embryonic development are tightly orchestrated by epigenetic mechanisms, among which histone modifications act as pivotal regulators. H3K27me3, one of the most functionally critical histone marks, exerts a repressive effect on gene expression, keeping developmental genes in a silent state until the precise stage is reached to ensure the fidelity of cell fate commitment. However, the exact molecular mechanisms by which H3K27me3 modulates early embryonic cell fate decisions remain incompletely understood.
To address this key question, a research team from the Chinese Academy of Medical Sciences (CAMS) and Guangzhou Institutes of Biomedicine and Health (GIBH) generated Pcgf1 -knockout models. PCGF1 is a core component of the non-canonical Polycomb repressive complex 1 (ncPRC1), which facilitates H2AK119 mono-ubiquitination (H2AK119ub) — a modification that subsequently recruits H3K27me3 through the regulatory factor JARID2. Their results showed that PCGF1 deficiency is embryonic lethal: no Pcgf1 -knockout mice survived to birth, and mutant embryos began to undergo resorption by embryonic day (E) 9.5. Notably, no obvious morphological or transcriptomic abnormalities were detected at E6.5, but subsequent gastrulation — a critical step in early embryonic patterning — was completely arrested. This finding confirms the essential role of PCGF1 in early embryogenesis, suggesting that cells in PCGF1-knockout embryos are trapped in a pluripotent state and fail to initiate lineage commitment.
To dissect the underlying mechanism, the team employed an in vitro definitive endoderm (DE) differentiation model of embryonic stem cells (ESCs). When PCGF1 was depleted, they observed a significant reduction in H3K27me3 levels at developmentally relevant genes. Counterintuitively, these developmental genes only exhibited mild upregulation, and the cells remained in a stem cell-like state without committing to the endodermal lineage. At the DE stage, transcriptomic analysis revealed that PCGF1-deficient cells had substantially lower expression of endoderm-specific marker genes compared to wild-type cells, accompanied by sustained high expression of pluripotency genes — a phenotype consistent with the in vivo embryonic arrest.
This paradoxical phenomenon led the team to hypothesize that dysregulation of pluripotency gene silencing might be the primary driver of failed cell fate transition. Further chromatin immunoprecipitation (ChIP) assays confirmed that, during normal DE differentiation, pluripotency genes acquire H3K27me3 modifications to induce their silencing, which is a prerequisite for lineage commitment. In contrast, PCGF1 depletion abrogated this H3K27me3 deposition on pluripotency genes, allowing their persistent expression. Concomitantly, PCGF1 deficiency led to increased recruitment of MLL2 (Deposition of H3K4me3) and UTX (Removal of H3K27me3) to chromatin in ESCs. This coordinated dysregulation disrupts the balance of epigenetic marks at key developmental loci.
Collectively, these findings delineate the central role of dynamic H3K27me3 remodeling in governing early lineage specification. H3K27me3 acts as a "molecular switch" that silences pluripotency programs to free cells from their undifferentiated state, while simultaneously priming bivalently expressed developmental genes for timely activation upon differentiation cues. PCGF1 safeguards this process by maintaining H3K27me3 homeostasis: it ensures the proper silencing of pluripotency genes through ncPRC1-mediated H2AK119ub-dependent H3K27me3 recruitment, while restricting the activity of H3K27me3-erasing (UTX) and H3K4me3-promoting (MLL2) factors to preserve epigenetic balance. By uncovering this regulatory network, the study provides critical insights into the molecular logic underlying early embryonic development.
Beyond advancing fundamental understanding of epigenetic regulation in cell fate decisions, this work opens new avenues for investigating the pathogenesis of developmental disorders linked to epigenetic dysregulation. It also offers valuable implications for refining strategies in regenerative medicine, as precise control of H3K27me3 dynamics could enhance the efficiency and fidelity of directed cell differentiation for therapeutic applications.
Science Bulletin